Hunan Cancer Hospital
Clinical trials sponsored by Hunan Cancer Hospital, explained in plain language.
-
New combo therapy targets rare lung cancer mutation
Disease control Recruiting nowThis study tests a new drug (firmonertinib) combined with radiation therapy for people with a specific type of stage III lung cancer that cannot be removed by surgery. The cancer must have a rare change in the EGFR gene. The goal is to see if the combination can delay cancer grow…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New combo attack on liver metastases from nasopharyngeal cancer enters human trials
Disease control Recruiting nowThis phase 2 trial tests whether adding low-dose radiation to standard chemoimmunotherapy can better control liver tumors in people with nasopharyngeal carcinoma that has spread to the liver. The study will enroll 26 adults aged 18 to 70. Participants will receive low-dose radiat…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Nutrition drink may ease throat pain during lung cancer radiation
Symptom relief Recruiting nowThis phase 3 trial tests whether a daily nutritional drink (Oral Impact®) can reduce severe throat and esophagus inflammation caused by chest radiation in lung cancer patients. About 121 adults with lung cancer who need radiation will drink two bottles a day during and for three …
Phase: PHASE3 • Sponsor: Hunan Cancer Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC